No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Evaluation of adjuvant treatments for T1 N0 M0 triple-negative breast cancer

byTeddy Guo

December 2, 2020

in StudyGraphics

Spironolactone use associated with improved outcomes for patients with HFpEF and resistant hypertension

RelatedReports

Quick Take: Diffusion-weighted Imaging of Invasive Breast Cancer: Relationship to Distant Metastasis–free Survival

Oncology

Breast cancer screening with MRI provides modest benefit for high-risk women

March 2, 2026

Preoperative bilateral breast imaging may reduce contralateral cancer recurrence

Oncology

Sacituzumab govitecan plus pembrolizumab improves survival in advanced triple-negative breast cancer

January 28, 2026

Age and breast cancer risk factors associated with false-positive mammography results

Chronic Disease

The addition of a carboplatin to standard of care adjuvant chemotherapy improves survival outcomes in patients with high-risk, early-stage triple-negative breast cancer

January 12, 2026

Admission may not be needed following sleep apnea surgery

Weekly Rewinds

2 Minute Medicine Rewind December 29th, 2025

January 12, 2026

#VisualAbstract: Effectiveness of lorlatinib in advanced anaplastic lymphoma kinase-positive lung cancer

#VisualAbstract: Rivaroxaban noninferior to warfarin in patients with atrial fibrillation and bioprosthetic mitral valves

Beta-blockers associated with worse outcomes in non-cardiac perioperative settings

Perioperative anticoagulation post robot-assisted radical prostatectomy not associated with increased high-grade bleeding risk

#VisualAbstract Renal Toxicity Associated with Carfilzomib in Multiple Myeloma Patients

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports